How the body fights human metapneumovirus (HMPV)
Host Determinants of Human Metapneumovirus Immunity and Pathogenesis
This project looks at how people's immune systems respond to HMPV—the virus that causes serious lung infections in children and some adults—to guide better drugs and vaccines.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11353697 on NIH RePORTER |
What this research studies
Researchers are using virus samples taken from real patients and testing them in lab models to find out why some strains cause severe illness. They are focusing on immune signals called type I and III interferons and on viral proteins that may block those signals. The team uses mouse models that get sick from patient-derived viruses so they can watch disease and immune responses in detail. Results will point to parts of the virus or immune system that could be targeted by new therapies or vaccines.
Who could benefit from this research
Good fit: People who recently had HMPV infection—especially young children, people with asthma or COPD, premature infants, or people with HIV—would be the most relevant to this work.
Not a fit: People without HMPV exposure or whose health problems are unrelated to respiratory viruses are unlikely to benefit directly from this project.
Why it matters
Potential benefit: Could point to targets for new antiviral drugs or vaccines and help prevent severe HMPV lung infections.
How similar studies have performed: Related lab and animal studies on similar respiratory viruses like RSV have revealed immune pathways that can be targeted, but HMPV-specific mechanisms are less well understood and using patient-derived virulent strains in mice is relatively new.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Williams, John V. — University of Wisconsin-Madison
- Study coordinator: Williams, John V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.